BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 3947233)

  • 1. LeVeen vs Denver peritoneovenous shunts for intractable ascites of cirrhosis. A randomized, prospective trial.
    Fulenwider JT; Galambos JD; Smith RB; Henderson JM; Warren WD
    Arch Surg; 1986 Mar; 121(3):351-5. PubMed ID: 3947233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TIPS versus peritoneovenous shunt in the treatment of medically intractable ascites: a prospective randomized trial.
    Rosemurgy AS; Zervos EE; Clark WC; Thometz DP; Black TJ; Zwiebel BR; Kudryk BT; Grundy LS; Carey LC
    Ann Surg; 2004 Jun; 239(6):883-9; discussion 889-91. PubMed ID: 15166968
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of refractory chylous ascites with peritoneovenous shunts.
    Huang Y; Gloviczki P; Duncan AA; Fleming MD; Driscoll DJ; Kalra M; Oderich GS; Bower TC
    J Vasc Surg Venous Lymphat Disord; 2017 Jul; 5(4):538-546. PubMed ID: 28623993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The LeVeen shunt in the elective treatment of intractable ascites in cirrhosis. A prospective study on 140 patients.
    Smadja C; Franco D
    Ann Surg; 1985 Apr; 201(4):488-93. PubMed ID: 3977450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complications of Denver peritoneovenous shunting.
    Lund RH; Moritz MW
    Arch Surg; 1982 Jul; 117(7):924-8. PubMed ID: 6979992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paracentesis with intravenous infusion of albumin as compared with peritoneovenous shunting in cirrhosis with refractory ascites.
    Ginès P; Arroyo V; Vargas V; Planas R; Casafont F; Panés J; Hoyos M; Viladomiu L; Rimola A; Morillas R
    N Engl J Med; 1991 Sep; 325(12):829-35. PubMed ID: 1875966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Denver peritoneovenous shunts for the management of malignant ascites: a review of the literature in the post LeVeen Era.
    White MA; Agle SC; Padia RK; Zervos EE
    Am Surg; 2011 Aug; 77(8):1070-5. PubMed ID: 21944526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peritoneovenous shunts in patients with intractable ascites: palliation at what price?
    Zervos EE; McCormick J; Goode SE; Rosemurgy AS
    Am Surg; 1997 Feb; 63(2):157-62. PubMed ID: 9012430
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Peritoneovenous shunts. Lessons learned from an eight-year experience with 70 patients.
    Fulenwider JT; Smith RB; Redd SC; Ansley JD; Henderson JM; Millikan WF; Galambos JT; Warren WD
    Arch Surg; 1984 Oct; 119(10):1133-7. PubMed ID: 6477096
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Denver peritoneovenous shunting for malignant or cirrhotic ascites. A prospective consecutive series.
    Söderlund C
    Scand J Gastroenterol; 1986 Dec; 21(10):1161-72. PubMed ID: 3809991
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Peritoneovenous shunting in intractable ascites of cirrhosis. Results of a prospective study on improving prognostic factors].
    Hillaire S; Labianca M; Smadja C; Grange D; Franco D
    Gastroenterol Clin Biol; 1988 Oct; 12(10):681-6. PubMed ID: 3220223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of Peritoneovenous Shunt for the Management of Refractory Ascites.
    Ayllón MD; Ciria R; Gómez-Luque I; Rodriguez-Perálvarez M; Padial A; Luque A; López-Cillero P; de la Mata M; Briceño J
    Transplant Proc; 2019; 51(1):41-43. PubMed ID: 30655143
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peritoneovenous shunting for intractable ascites.
    Tyden G; Samnegård H; Thulin L
    Acta Chir Scand; 1982; 148(7):597-600. PubMed ID: 7168289
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peritoneovenous shunting for intractable cirrhotic and cancerous ascites using different types of shunting tubes.
    Akimaru K; Ueda Y; Shoji T
    Jpn J Surg; 1988 Sep; 18(5):502-8. PubMed ID: 3230724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronological Course and Clinical Features after Denver Peritoneovenous Shunt Placement in Decompensated Liver Cirrhosis.
    Koyama S; Nogami A; Yoneda M; Cheng S; Koike Y; Takeuchi Y; Iwaki M; Kobayashi T; Saito S; Utsunomiya D; Nakajima A
    Tomography; 2024 Mar; 10(4):471-479. PubMed ID: 38668394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peritoneovenous shunts palliate malignant ascites.
    Edney JA; Hill A; Armstrong D
    Am J Surg; 1989 Dec; 158(6):598-601. PubMed ID: 2480068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intractable ascites treated with peritoneovenous shunts (LeVeen). A 24- to 64-month follow-up of results in 52 alcoholic cirrhotics.
    Greenlee HB; Stanley MM; Reinhardt GF
    Arch Surg; 1981 May; 116(5):518-24. PubMed ID: 7235944
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Experience with LeVeen peritoneal-venous shunt in the treatment of intractable cirrhotic ascites].
    Chen YR; Chen MC
    Zhonghua Nei Ke Za Zhi; 1983 Jul; 22(7):431-3. PubMed ID: 6641389
    [No Abstract]   [Full Text] [Related]  

  • 19. Percutaneous peritoneovenous shunt creation for the treatment of benign and malignant refractory ascites.
    Park JS; Won JY; Park SI; Park SJ; Lee DY
    J Vasc Interv Radiol; 2001 Dec; 12(12):1445-8. PubMed ID: 11742023
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bizarre complications of peritoneovenous shunts.
    Eckhauser FE; Strodel WE; Girardy JW; Turcotte JG
    Ann Surg; 1981 Feb; 193(2):180-4. PubMed ID: 7469552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.